Drug Channels Archive for January, 2022

Click a link below to view the mailing archive as if it had been sent to you.

2022-01-28 07:46Drug Channels - Betting Big on Biosimilars: How Evolving Market Dynamics Will Impact Patient Access
2022-01-25 07:46Drug Channels News Roundup, January 2022: Insulin G2N Update; OptumRx “Data,” HDHPs, 340B Projections, and Fun with the CDC
2022-01-21 07:46Drug Channels - Four Big Implications for Patients and the Prescription Journey in 2022
2022-01-19 07:46Drug Channels - Five Takeaways from the Big Three PBMs' 2022 Formulary Exclusions
2022-01-18 07:46NEW: The Drug Channels 2022 Video Webinar Series
2022-01-14 07:46Drug Channels - The 340B Rebate Model: A Solution to the Contract Pharmacy Controversy
2022-01-11 07:46Drug Channels - The Retail Pharmacy Outlook for 2022
2022-01-10 07:36Drug Channels - PCMA Business Forum
2022-01-04 07:46Drug Channels - Tales of the Unsurprised: Brand-Name Drug Prices Fell for the Fourth Consecutive Year


<< Archive IndexSubscribe >>